Next Article in Journal / Special Issue
Imaging of Convection Enhanced Delivery of Toxins in Humans
Previous Article in Journal
The Biology of the Cytolethal Distending Toxins
Article Menu

Export Article

Open AccessReview
Toxins 2011, 3(3), 191-200;

Monitoring Radiographic Brain Tumor Progression

Division of Neurosurgery, Duke University Medical Center, Box 3807, Durham, NC 27710, USA
Author to whom correspondence should be addressed.
Received: 31 January 2011 / Revised: 3 February 2011 / Accepted: 11 March 2011 / Published: 15 March 2011
(This article belongs to the Special Issue Immunotoxins)
Full-Text   |   PDF [190 KB, uploaded 15 March 2011]   |  


Determining radiographic progression in primary malignant brain tumors has posed a significant challenge to the neuroncology community. Glioblastoma multiforme (GBM, WHO Grade IV) through its inherent heterogeneous enhancement, growth patterns, and irregular nature has been difficult to assess for progression. Our ability to detect tumor progression radiographically remains inadequate. Despite the advanced imaging techniques, detecting tumor progression continues to be a clinical challenge. Here we review the different criteria used to detect tumor progression, and highlight the inherent challenges with detection of progression. View Full-Text
Keywords: glioblastoma; radiographic progression; tumor progression; MRI glioblastoma; radiographic progression; tumor progression; MRI

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Mehta, A.I.; Kanaly, C.W.; Friedman, A.H.; Bigner, D.D.; Sampson, J.H. Monitoring Radiographic Brain Tumor Progression. Toxins 2011, 3, 191-200.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top